Importantly, activation of oncogenes, such as MYC, or mutant KRAS or NOTCH, results in the upregulation of cellular SUMOylation, pointing to a role of enhanced SUMOylation in tumor formation or progression. This evidence concerns the gene MYC and neoplasm.